Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
144
datasets available to search
ShareScore release 0.9.0
Dataset results
144 results for “Fibroblast Growth Factors”
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
ClinicalTrials.gov study NCT05052801. IPD Sharing: YES. Countries: 37. Publications: 3.
Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
ClinicalTrials.gov study NCT01748812. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
ClinicalTrials.gov study NCT01660308. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Effect of Macronutrients on Fibroblast Growth Factor 21 (FGF21) Secretion
ClinicalTrials.gov study NCT05061485. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients
ClinicalTrials.gov study NCT06668831. IPD Sharing: UNDECIDED. Countries: 1. Publications: 10.
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)
ClinicalTrials.gov study NCT01015404. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastroint
ClinicalTrials.gov study NCT04595747. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)
ClinicalTrials.gov study NCT00734708. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation
ClinicalTrials.gov study NCT02958839. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02053636. IPD Sharing: YES. Countries: 9. Publications: 1.
Low-Phosphate Diet and Fibroblast Growth Factor-23 Level
ClinicalTrials.gov study NCT03367338. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
ClinicalTrials.gov study NCT02368951. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Data from: A study on genetic variants of Fibroblast Growth Factor Receptor 2 (FGFR2) and the risk of breast cancer from North India
Open the record for dataset details and reuse information.
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
ClinicalTrials.gov study NCT02307916. IPD Sharing: NO. Countries: 1. Publications: 0.
Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus
ClinicalTrials.gov study NCT01858597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fibroblast Growth Factor 23 in Chronic Respiratory Failure
ClinicalTrials.gov study NCT05258370. IPD Sharing: YES. Countries: 0. Publications: 4.
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT06625593. IPD Sharing: YES. Countries: 4. Publications: 0.
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease
ClinicalTrials.gov study NCT00999037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2
ClinicalTrials.gov study NCT00514657. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway
ClinicalTrials.gov study NCT01868022. IPD Sharing: YES. Countries: 7. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.